That changed in December 2024, when NICE recognized the drugs cost-effectiveness and approved its inclusion on the NHS formulary, enabling more patients to access treatment
Ferhatbegovic L, Mrsic D, Macic-Dzankovic A
Medicare Part D coverage begins July 1, 2026
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2 trial (Lancet Diabetes Endocrinol)
The study also pointed out that some websites promoting GLP-1s sell compounded versions of the drugs that are not FDA-approved, have not been tested for safety, and can be risky for patients, the US Food and Drug Administration warns
But is the body able to take in a certain amount and to break it down, you might have a benefit where you see maybe in the first couple of days of a shot, even at a low dose, you may see benefit where not having them increase their fiber on days one and day two, but like starting at day three to increase their fiber